Citation Impact
Citing Papers
Characterization of a canine homolog of hepatitis C virus
2011 StandoutNobel
A sex-biased imbalance between Tfr, Tph, and atypical B cells determines antibody responses in COVID-19 patients
2023 StandoutNobel
Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality
2020 StandoutNobel
Evidence for a functional RNA element in the hepatitis C virus core gene
2007 StandoutNobel
Mouse models of acute and chronic hepacivirus infection
2017 StandoutScienceNobel
Hepatitis C Virus Infection Induces the Beta Interferon Signaling Pathway in Immortalized Human Hepatocytes
2007
PNA hybridizes to complementary oligonucleotides obeying the Watson–Crick hydrogen-bonding rules
1993 StandoutNature
Determinants of outcome of compensated hepatitis C virus-related cirrhosis
1998
Interferon for the Treatment of Chronic Hepatitis C in Patients Infected with Human Immunodeficiency Virus
1996
Hepatitis C Virus Infection
2001 Standout
Role of Transforming Growth Factor β in Human Disease
2000 Standout
Selection of Antisense Oligonucleotides on the Basis of Genomic Frequency of the Target Sequence
1994
Rising Incidence of Hepatocellular Carcinoma in the United States
1999 Standout
Unravelling hepatitis C virus replication from genome to function
2005 StandoutNatureNobel
Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells
1993 StandoutNature
CpG motifs in bacterial DNA trigger direct B-cell activation
1995 StandoutNature
HEPATITIS C VIRUS AND ORGAN TRANSPLANTATION
1996
Impracticability of Informed Consent in the Registry of the Canadian Stroke Network
2004 Standout
Indoleamine 2,3‐dioxygenase in T‐cell tolerance and tumoral immune escape
2008
Tumor suppressor genes
1991 Standout
A 10-Year Experience of Liver Transplantation for Hepatitis C: Analysis of Factors Determining Outcome in Over 500 Patients
2001
Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology
2006 StandoutNobel
The RNA Sensor RIG-I Dually Functions as an Innate Sensor and Direct Antiviral Factor for Hepatitis B Virus
2014 StandoutNobel
Meta–Analysis of Interferon Randomized Trials in the Treatment of Viral Hepatitis C: Effects of Dose and Duration
1996
Oligonucleoside Methylphosphonates as Antisense Reagents
1991
Combined treatment with interferon alpha‐2b and ribavirin for chronic hepatitis C in patients with a previous non‐response or non‐sustained response to interferon alone
1995
Prospects for a vaccine against the hepatitis C virus
2005 StandoutNatureNobel
Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection.
1996 StandoutNobel
Antisense Oligonucleotides as Therapeutic Agents—Is the Bullet Really Magical?
1993 Science
Living in the liver: hepatic infections
2012
Effect of a single 3′-methylene phosphonate linkage on the conformation of an A-DNA octamer double helix
1991
A long-range RNA–RNA interaction between the 5′ and 3′ ends of the HCV genome
2009
Predicting HLA CD4 Immunogenicity in Human Populations
2018
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
2020 Standout
Conjugates of oligonucleotides and modified oligonucleotides: a review of their synthesis and properties
1990
Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List
2008 Standout
Sarcoidosis
1997 Standout
Primary Biliary Cirrhosis
1996
Interferon gamma‐1b for the treatment of fibrosis in chronic hepatitis C infection
2006
A randomized trial of ribavirin and interferon-α vs. interferon-α alone in patients with chronic hepatitis C who were non-responders to a previous treatment
1999
Interferon therapy in chronic hepatitis C virus infection
1994
Transforming Growth Factor β in Tissue Fibrosis
1994 Standout
Animal Models for Hepatitis C
2013
Crystal Structure of the Hepatitis C Virus NS3 Protease Domain Complexed with a Synthetic NS4A Cofactor Peptide
1996 StandoutNobel
A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C
2013
The basics of epithelial-mesenchymal transition
2009 Standout
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Antisense and ribozyme constructs in transgenic animals
1996
Hepatitis C virus 3′UTR regulates viral translation through direct interactions with the host translation machinery
2013 StandoutNobel
Tolerance and efficacy of oral ribavirin treatment of chronic hepatitis C: A multicenter trial
1997
Antibodies Against Hepatitis C Virus-Like Particles and Viral Clearance in Acute and Chronic Hepatitis C
2000
The Risk of Transfusion-Transmitted Viral Infections
1996 Standout
Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido
2011 StandoutNobel
Infection in Solid-Organ Transplant Recipients
2007 Standout
Natural history of liver fibrosis progression in patients with chronic hepatitis C
1997 Standout
Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C
1998 Standout
Antisense phosphorothioate oligodeoxynucleotides: introductory concepts and possible molecular mechanisms of toxicity
1995
Long-term follow-up of chronic hepatitis C patients with sustained virological response to alpha-interferon
1999
Interferon for non-A, non-B chronic hepatitis
1991
Mixed backbone antisense oligonucleotides: design, biochemical and biological properties of oligonucleotides containing 2'-5'-ribo- and 3'- 5'-deoxyribonucleotide segments
1997
Hepatitis C: Natural History of a Unique Infection
1995
Infection in Organ-Transplant Recipients
1998 Standout
Hepatitis C virus infection of mononuclear cells from peripheral blood and liver infiltrates in chronically infected patients
1995
Molecular mechanisms of action of antisense drugs
1999
Comparison of Cellular Binding and Uptake of Antisense Phosphodiester, Phosphorothioate, and Mixed Phosphorothioate and Methylphosphonate Oligonucleotides
1993
Transforming growth factor beta 1 suppression of c-myc gene transcription: role in inhibition of keratinocyte proliferation.
1990
Prospective Comparison of Whole-Blood- and Plasma-Based Hepatitis C Virus RNA Detection Systems: Improved Detection Using Whole Blood as the Source of Viral RNA
1999
Hepatocellular Carcinoma
2019 Standout
Replication of Subgenomic Hepatitis C Virus RNAs in a Hepatoma Cell Line
1999 StandoutScience
Variability of hepatitis C virus
1995
Immunology and the liver
1991
Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C
2005 StandoutNobel
Nonviral Vectors for Gene Delivery
2008 Standout
Primary Biliary Cirrhosis
2011 Standout
Functional Role of Type I and Type II Interferons in Antiviral Defense
1994 StandoutScience
Implicit Solvation Models: Equilibria, Structure, Spectra, and Dynamics
1999 Standout
Variability of hepatitis C virus
1995
G Protein-Coupled Receptors: Functional and Mechanistic Insights Through Altered Gene Expression
1998 StandoutNobel
Copper-Catalyzed Synthesis of Mixed Alkyl Aryl Phosphonates
2014 StandoutNobel
Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems
2001 StandoutNobel
Electrochemiluminescence (ECL)
2004 Standout
Antisense oligodeoxynucleotide phosphorothioate complementary to Gag mRNA blocks replication of human immunodeficiency virus type 1 in human peripheral blood cells.
1994
Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice.
1991
Pax-2 is required for mesenchyme-to-epithelium conversion during kidney development
1993
Genetic diversity and evolution of hepatitis C virus – 15 years on
2004
Characterization of hepatitis C virus replication in cloned cells obtained from a human T-cell leukemia virus type 1-infected cell line, MT-2
1996
A Field Guide to Foldamers
2001 Standout
Transforming Growth Factors β1 and α in Chronic Liver Disease
1991
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Glutathione-Sensitive Stabilization of Block Copolymer Micelles Composed of Antisense DNA and Thiolated Poly(ethylene glycol)-block-poly(l -lysine): A Potential Carrier for Systemic Delivery of Antisense DNA
2001
Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays
1998 Standout
Ribavirin as Therapy for Chronic Hepatitis C
1995
Cytokine therapeutics: lessons from interferonalpha.
1994
Hepatitis C Virus: Evading the Intracellular Innate Immunity
2020
Conformational Flexibility of Phosphate, Phosphonate, and Phosphorothioate Methyl Esters in Aqueous Solution
1998 StandoutNobel
Improved Detection of Hepatitis B Virus Surface Antigen by a New Rapid Automated Assay
1999
Chemical Chaperones Reduce ER Stress and Restore Glucose Homeostasis in a Mouse Model of Type 2 Diabetes
2006 StandoutScience
A simple preparation of 5′-o-dimethoxytrityl deoxyribonucleoside 3′-o-phosphorbisdiethylamidites as useful intermediates in the synthesis of oligodeoxyribonucleotides and their phosphorodiethylamidate analogs on a solid support
1989
Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles
2004 StandoutNobel
Acid/Azole Complexes as Highly Effective Promoters in the Synthesis of DNA and RNA Oligomers via the Phosphoramidite Method
2001 StandoutNobel
The Yin and Yang of regulatory T cells in infectious diseases and avenues to target them
2017
Works of M.P. Civeira being referenced
N -Acetyl Cysteine Enhances the Response to Interferon-α in Chronic Hepatitis C: A Pilot Study
1993
Prediction of the response of chronic hepatitis C to interferon alfa: a statistical analysis of pretreatment variables.
1993
Phosphoramidate, Phosphorothioate, and Methylphosphonate Analogs of Oligodeoxynucleotide : Inhibitors of Replication of Human Immunodeficiency Virus
1989
Altered expression and activation of signal transducers and activators of transcription (STATs) in hepatitis C virus infection: in vivo and in vitro studies
2005
Randomised trial of lymphoblastoid α-interferon in chronic hepatitis C
1993
HCV structural proteins interfere with interferon-alpha Jak/STAT signalling pathway
2007
Ribavirin in the treatment of chronic hepatitis C unresponsive to alfa interferon
1993
Risk factors for recurrence of hepatitis C after liver transplantation
1998
Hepatitis B virus occult infection in subjects with persistent isolated anti-HBc reactivity
1993
Defective immunoregulation in primary biliary cirrhosis: CD4+, Leu-8+ T cells have abnormal activation and suppressor function in vitro
1989
Characterization of T‐cell responses against immunodominant epitopes from hepatitis C virus E2 and NS4a proteins
2005
Histological outcome of chronic hepatitis C treated with a 12‐month course of lymphoblastoid alfa interferon
1993
Suppressor T‐cell activity in chronic hepatitis B‐virus infection: Relationship with the presence of HBV‐DNA in serum
1989
Replication of hepatitis C virus in peripheral blood mononuclear cells
1992
Effectiveness of long term lymphoblastoid interferon (L-IFN) treatment in chronic hepatitis C (CHC)
1990
Oligodeoxynucleoside phosphoramidates and phosphorothioates as inhibitors of human immunodeficiency virus.
1988
Immunogenicity of variable regions of hepatitis C virus proteins: selection and modification of peptide epitopes to assess hepatitis C virus genotypes by ELISA.
1999
Randomized trial of lymphoblastoid alpha interferon in chronic non-A, non-B hepatitis: Effects on inflammation and fibrogenesis
1989
Inhibition of acquired immunodeficiency syndrome virus by oligodeoxynucleoside methylphosphonates.
1988
Hepatic and extrahepatic HCV RNA strands in chronic hepatitis C: Different patterns of response to interferon treatment
1993
Hepatitis C virus infection of primary tupaia hepatocytes leads to selection of quasispecies variants, induction of interferon-stimulated genes and NF-κB nuclear translocation
2005
Inhibition of human immunodeficiency virus replication by antisense oligodeoxynucleotides.
1988
Upregulation of Indoleamine 2,3-Dioxygenase in Hepatitis C Virus Infection
2007